As of 2026-09-15, the EV/EBITDA ratio of Medifast Inc (MED) is -10.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Medifast's latest enterprise value is 61.53 mil USD. Medifast's TTM EBITDA according to its financial statements is -5.70 mil USD. Dividing these 2 quantities gives us the above Medifast EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 3.5x - 8.0x | 5.4x |
| Forward P/E multiples | 7.9x - 13.7x | 10.9x |
| Fair Price | 4.68 - 8.24 | 5.80 |
| Upside | -61.0% - -31.3% | -51.6% |
| Date | EV/EBITDA |
| 2026-09-11 | -10.88 |
| 2026-09-10 | -10.90 |
| 2026-09-09 | -11.07 |
| 2026-09-08 | -11.11 |
| 2026-09-04 | -12.03 |
| 2026-09-03 | -11.85 |
| 2026-09-02 | -12.11 |
| 2026-09-01 | -10.98 |
| 2026-08-31 | -11.07 |
| 2026-08-28 | -11.15 |
| 2026-08-27 | -11.11 |
| 2026-08-26 | -11.23 |
| 2026-08-25 | -11.11 |
| 2026-08-24 | -10.80 |
| 2026-08-21 | -10.70 |
| 2026-08-20 | -10.06 |
| 2026-08-19 | -9.98 |
| 2026-08-18 | -9.41 |
| 2026-08-17 | -9.71 |
| 2026-08-14 | -9.71 |
| 2026-08-13 | -9.79 |
| 2026-08-12 | -10.00 |
| 2026-08-11 | -10.12 |
| 2026-08-10 | -10.98 |
| 2026-08-07 | -12.01 |
| 2026-08-06 | -11.03 |
| 2026-08-05 | -11.35 |
| 2026-08-04 | -12.91 |
| 2026-08-03 | -6.39 |
| 2026-07-31 | -6.56 |
| 2026-07-30 | -6.72 |
| 2026-07-29 | -6.19 |
| 2026-07-28 | -6.41 |
| 2026-07-27 | -6.72 |
| 2026-07-24 | -6.27 |
| 2026-07-23 | -5.82 |
| 2026-07-22 | -6.43 |
| 2026-07-21 | -7.91 |
| 2026-07-20 | -7.64 |
| 2026-07-17 | -7.40 |
| 2026-07-16 | -7.87 |
| 2026-07-15 | -8.13 |
| 2026-07-14 | -8.09 |
| 2026-07-13 | -8.91 |
| 2026-07-10 | -8.30 |
| 2026-07-09 | -8.22 |
| 2026-07-08 | -8.20 |
| 2026-07-07 | -8.63 |
| 2026-07-06 | -8.93 |
| 2026-07-02 | -8.77 |